Research Article

The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head

Figure 1

Effect of different concentrations of PRCR on UC-MSC proliferation. CCK-8 assay indicated that the UC-MSCs treated with 2% PRCR achieved maximum proliferation. ; , compared to the other group. PRCR: platelet-rich plasma clot releasate; UC-MSCs: umbilical cord mesenchymal stem cells; CCK-8: cell counting kit-8 assay.